DWS CROCI(R) Equity Dividend FundKDHAX
Type
Mutual fund
Peer group
US equity: large companies
Net assets
$815.4M
Expense ratio
1.02%
1-year return
+7.6%
3 years, a year
+10.2%
5 years, a year
+9.6%
Holdings
44
What it aims to do.
The fund seeks to achieve a high rate of total return.
Top 10 holdings.
| Holding | % of fund |
|---|---|
| MRK Merck & Co Inc | 2.68% |
| JNJ Johnson & Johnson | 2.66% |
| SJM J M Smucker Co/The | 2.65% |
| AMGN Amgen Inc | 2.63% |
| LMT Lockheed Martin Corp | 2.61% |
| BMY Bristol-Myers Squibb Co | 2.61% |
| HAL Halliburton Co | 2.61% |
| PFE Pfizer Inc | 2.60% |
| QCOM QUALCOMM Inc | 2.60% |
| JOBY Amcor PLC | 2.56% |
More on KDHAX.
- KDHAX overview
- KDHAX holdings
- KDHAX risk
- KDHAX costs
- KDHAX money in and out
- KDHAX share classes
- Compare KDHAX with other funds
Returns after fees, from the fund's SEC filings up to Feb 2026. Past returns are not a promise. Not financial advice.